Drug intelligence / Profile preview

Fli-HA platform-based gynecology product

Development stage: Preclinical
Lead developer: Fount Bio
Modality: Hydrogel Systems → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Intravaginal, Topical

Overview

Fli-HA is a proprietary technology platform developed by Fount Bio that utilizes bioorthogonal chemistry to create durable forms of hyaluronic acid (HA) for medical applications. The core innovation allows tailored placement and extended retention of large glycopolymers like HA on or within tissues. While the lead clinical product is Flī-Derm for dermatology, the company has an active pipeline developing similar products for ophthalmology and gynecology indications. The mechanism involves building stable HA matrices at targeted tissue sites, potentially improving local tissue hydration, repair, or barrier function. The primary developer is Fount Bio[1][2].

Other names: Fli-HA platform-based gynecology productFlī-HA technology platform

Targets

ICAM1 (Intercellular Adhesion Molecule 1)RHAMM (Hyaluronan-mediated motility receptor)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)CD44 (CD44 antigen)STAB2 (Stabilin-2)

Beyond the preview

Go deeper on Fli-HA platform-based gynecology product.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fli-HA platform-based gynecology product.

Explore the full profile